Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 USD | -3.09% | +1.20% | -29.67% |
Chart calendar Galmed Pharmaceuticals Ltd.
Upcoming events on Galmed Pharmaceuticals Ltd.
Past events on Galmed Pharmaceuticals Ltd.
2024-03-13 | Q4 2023 Earnings Release (Projected) |
2023-06-20 09:00 am | Maxim Group Virtual Healthcare Conference |
2023-06-01 08:00 am | Q1 2023 Earnings Release |
2023-05-04 10:00 am | Annual General Meeting |
2022-08-04 08:00 am | Interim 2022 Earnings Release |
2022-05-17 08:00 am | Q1 2022 Earnings Release |
2022-05-02 08:30 am | FY 2021 Earnings Call |
2022-05-02 07:00 am | FY 2021 Earnings Release |
2021-11-11 | AASLD The Liver Meeting |
2021-11-08 08:30 am | Q3 2021 Earnings Call - ARMOR Phase 3 Study Update |
2021-11-08 07:30 am | Q3 2021 Earnings Release |
2021-08-05 08:30 am | Interim 2021 Earnings Call |
2021-08-05 07:00 am | Interim 2021 Earnings Release |
2021-05-13 08:30 am | Q1 2021 Earnings Call |
2021-05-13 07:50 am | Q1 2021 Earnings Release |
2021-03-18 08:30 am | FY 2020 Earnings Call |
2021-03-18 07:00 am | FY 2020 Earnings Release |
2020-11-18 08:00 am | Stifel Healthcare Conference |
2020-11-12 08:30 am | Q3 2020 Earnings Call |
2020-11-12 07:00 am | Q3 2020 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,04 2,17 -5.91% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -20,1 -20,0 -0.55% | -28,1 -23,3 -20.62% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -10,7 -9,46 -13.22% | -22,4 -21,6 -3.78% | -30,2 -27,7 -9.15% | -32,9 -34,2 3.75% | -17,7 -18,9 6.43% | -8,20 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,78 -9,00 -8.68% | -20,5 -19,8 -3.27% | -28,8 -26,2 -9.61% | -32,5 -33,6 3.28% | -17,9 -18,9 5.32% | -7,75 |
Net income Million USD | Released Forecast Spread | -9,86 -8,94 -10.26% | -20,5 -19,8 -3.27% | -28,8 -26,2 -9.61% | -32,5 -33,5 3.11% | -17,9 -18,9 5.32% | -7,75 |
EPS USD | Released Forecast Spread | -8,10 -7,41 -9.37% | -14,5 -14,1 -3.47% | -20,2 -18,6 -9.05% | -19,8 -19,8 0.15% | -10,6 -11,2 5.33% | -2,63 |
Announcement Date | 13/03/19 | 12/03/20 | 18/03/21 | 02/05/22 | 29/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | -7,83 -6,80 -15.21% | |||||||||
EBIT Million USD | Released Forecast Spread | -7,85 -9,18 14.53% | -7,49 -8,95 16.3% | -6,09 -8,27 26.36% | -3,73 -6,56 43.11% | -5,38 -4,19 -28.32% | -2,45 -3,66 33.11% | -2,00 -2,50 19.86% | -1,87 -2,04 8.37% | -1,47 -1,97 25.6% | -2,35 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,71 -9,08 15.01% | -7,45 -8,55 12.83% | -6,14 -8,25 25.56% | -3,37 -6,54 48.39% | -5,35 -4,16 -28.54% | -2,64 -3,64 27.54% | -1,83 -2,50 26.74% | -1,59 -2,04 21.99% | -1,47 -1,97 25.34% | -2,35 |
Net income Million USD | Released Forecast Spread | -7,71 -9,08 15.01% | -7,45 -8,55 12.83% | -6,14 -8,25 25.56% | -3,37 -6,54 48.39% | -5,35 -4,16 -28.54% | -2,64 -3,64 27.54% | -1,83 -2,50 26.74% | -1,59 -2,04 21.99% | -1,47 -1,97 25.34% | -2,35 |
EPS USD | Released Forecast Spread | -4,65 -5,37 13.41% | -4,50 -4,54 0.83% | -3,60 -4,80 25% | -2,25 -3,54 36.44% | -3,15 -2,48 -27.27% | -1,50 -2,10 28.57% | -1,09 -1,50 27.33% | -0,95 -0,34 -179.41% | -0,24 -0,27 11.11% | -0,32 |
Announcement Date | 08/11/21 | 02/05/22 | 17/05/22 | 04/08/22 | 16/11/22 | 29/03/23 | 01/06/23 | 09/08/23 | 22/11/23 | - |
Past sector events for Galmed Pharmaceuticals Ltd.
Today | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
2024-03-27 07:00 am | ALTIMMUNE, INC.: Q4 2023 Earnings Release |
2024-03-26 | LEPU BIOPHARMA CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | REMEGEN CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | PHILOGEN S.P.A.: Q4 2023 Earnings Release |
2024-03-26 | ASCENTAGE PHARMA GROUP INTERNATIONAL: Q4 2023 Earnings Release |
2024-03-26 01:16 pm | KEYMED BIOSCIENCES INC.: Q4 2023 Earnings Release |
2024-03-24 | IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.: Q4 2023 Earnings Release |
2024-03-24 | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-21 04:01 pm | DIANTHUS THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Galmed Pharmaceuticals Ltd. - Nasdaq
- Calendar Galmed Pharmaceuticals Ltd.